Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Press Releases
Sort By
Newest First
1 / 154
1 / 154
Appointment
Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
Bio-Techne Corporation
PR-01-25-NI-34
Feb 04, 2025
Annual Conference
DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
DURECT Corporation
PR-01-25-NI-33
Feb 04, 2025
Announcement
Cyrano Therapeutics Launches Clinical Study of CYR-064 for Smell Loss (Hyposmia) in Parkinson's Disease Patients.
Cyrano Therapeutics
PR-01-25-NI-32
Feb 04, 2025
Announcement
Sano Chemicals Inc Announces Approval to Start Phase 1 MAD Study
Sano Chemicals Inc
PR-01-25-NI-30
Feb 04, 2025
Announcement
Avirmax Biopharma Completes First Cohort Enrollment in ABI-110 Gene Therapy Trial for Wet AMD, Including PCV.
Avirmax Biopharma
PR-01-25-NI-31
Feb 04, 2025
FDA
Roche receives FDA 510(k) clearance for the first blood test in the U.S. measuring Lp(a) in molar units
Roche
PR-01-25-NI-29
Feb 03, 2025
Drug Development
Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Helix
PR-01-25-NI-28
Feb 03, 2025
Financing
Vetigenics Secures $6 Million Seed Financing, Sees Meaningful Clinical Progress
Vetigenics
PR-01-25-NI-27
Feb 03, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Jan 24, 2025
FDA
Clarity Receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in Biochemical Recurrence of Prostate Cancer
Clarity
PR-01-25-NI-25
Jan 24, 2025
Extension
Sapient Teams with Alamar Biosciences to Advance Proteomics Using NULISA™ Assays for Cytokines, Chemokines, and Inflammation
Sapient
PR-01-25-NI-24
Jan 21, 2025
Clinic
Chromatin Bioscience's Synthetic Promoter Supports EsoBiotec's ESO-T01 CAR-T Therapy As It Enters the Clinic
Chromatin Bioscience
PR-01-25-NI-23
Jan 20, 2025
Announcement
NorthX Biologics Appoints Patrick DePalma Senior Vice President of North American Business Development
NorthX Biologics
PR-01-25-NI-22
Jan 20, 2025
Announcement
Caris Life Sciences Strategically Collaborates with Ontada to Advance Oncology Research and the Adoption of Precision Medicine
Caris Life Sciences
PR-01-25-NI-21
Jan 20, 2025
DPX
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a Market Projected to Grow to USD$48,000,000,000 by 2030
BioVaxys Technology Corp
PR-01-25-NI-20
Jan 17, 2025
FDA
Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65 Powered by AxcynDOT™ Technology
Axcynsis Therapeutics
PR-01-25-NI-19
Jan 16, 2025
Clinical CRO
Regulatory Approval Clears Path for Oncolytics Biotech to Pancreatic Cancer Treatment
Oncolytics Biotech
PR-01-25-NI-18
Jan 16, 2025
Business
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
Samsung Biologics
PR-01-25-NI-17
Jan 16, 2025
Clinical Trials
Gene Therapeutics (NGGT) Announces Publication of Early Clinical Trial Results for the Treatment of Bietti's Crystalline Dystrophy
NGGT Inc.
PR-01-25-NI-16
Jan 16, 2025
Announcement
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
Cryoport
PR-01-25-NI-15
Jan 16, 2025
